AzTrials
AzTrials

StrokeNCT03935113

Effects of Kinesio Taping for Upper Limb Function of Stroke Patients

A study testing Kinesio taping in people with Stroke, run by Taipei Medical University WanFang Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients with stroke in the brain, due to central nervous system damage, lack of correct action patterns, limited joint movement of upper limbs, affecting the patient's performance. The Kinesio taping effect is to facilitate the muscle activity of upper limb. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Stroke
What is being tested?
Kinesio taping
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1 participants
Where
1 siteTaiwan
Study dates
1 May 2019to 30 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Post-stroke hemiplegia, at least 6 months since onset
  • Ability to communicate and understand instructions.

Who cannot join

  • Skin problems, wounds, or infection on the affected upper limb.
  • The experience of using the Kinesio taping.
  • A history of allergy tothe Kinesio taping.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Wang Fang hospital

    Taipei, Taipei City

Other trials in Taiwan

About this study

Patients with stroke in the brain, due to central nervous system damage, lack of correct action patterns, limited joint movement of upper limbs, affecting the patient's performance. The Kinesio taping effect is to facilitate the muscle activity of upper limb. This program is intended to provide a treatment for patients with chronic stroke, and to observe their upper limb movements before and after using the Kinesio taping.

Read the detailed description

Motor impairment is the main cause of disability after stroke, leading to major health problems. Research has shown that the most common consequence of stroke is the paresis of limbs.The ability to live independently after a stroke depends on the recovery of motor functions,particularly those of the upper limb.The core concept of the Kinesio taping is to influence the brain through the sensory input, stimulate the nervous system, and improve the motor performance of the stroke patient.

Conditions
Stroke
Being tested
Kinesio taping
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kinesio tapingOther

    In KT group, KT was applied using the insertion-origin muscle and space-correction technique of affected upper limb with stroke patients.

Study groups in NCT03935113
Study groupRoleWhat they receive
KT groupExperimentalThe paretic upper limb is a common consequence of stroke that increases activity limitation.
Receives: Other: Kinesio taping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Fugl-Meyer Assessment (FMA) from pre to post-intervention.

    The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia.

    Measured: up to 30 minutes.

  2. Change in Action Research Arm Test (ARAT) from pre to post-intervention.

    The Action Research Arm Test (ARAT) is an evaluative measure to assess specific changes in limb function among post-stroke hemiplegia.

    Measured: up to 30 minutes.

  3. Change in Box and Block Test (BBT) from pre to post-intervention.

    The Box and Block Test (BBT) measures unilateral gross manual dexterity for stroke patients.

    Measured: up to 30 minutes.

Secondary outcomes (1)
  1. Change in Motor Activity Log (MAL) from pre to post-intervention.

    The Motor Activity Log (MAL) is a semi-structured interview to assess arm function.

    Measured: up to 20 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2019
  2. Study start1 May 2019
  3. Primary completion30 Jul 2020
  4. Study completion30 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03935113
Sponsor's protocol ID
N201811021
Status last verified
May 2019
First submitted
30 Apr 2019
Last updated
12 Aug 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Kinesio taping in people with Stroke, run by Taipei Medical University WanFang Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Fugl-Meyer Assessment (FMA) from pre to post-intervention. (time frame: up to 30 minutes.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2022; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in